# Safety and Efficacy Study of a New Intermittent Pneumatic Compression Device to Treat Patients With Peripheral Arterial Disease (PAD) Stage II

> **NCT00762086** · NA · COMPLETED · sponsor: **Mego Afek Ltd.** · enrollment: 67 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DEVICE:** AngioPress Intermittent pneumatic compression (IPC) Device
- **OTHER:** Medications and Standard walking exercises

## Key facts

- **NCT ID:** NCT00762086
- **Lead sponsor:** Mego Afek Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2012-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00762086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00762086, "Safety and Efficacy Study of a New Intermittent Pneumatic Compression Device to Treat Patients With Peripheral Arterial Disease (PAD) Stage II". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00762086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*